Catalyst Crew Technologies Corp. (OTC: CCTC), a digital health and artificial intelligence technology company, provided an update on the development of its telehealth platform infrastructure as part of its broader digital health strategy. The announcement details the company's progress in building a platform designed to support remote patient engagement, care coordination, and integration of AI-driven healthcare analytics tools within a technology-enabled healthcare environment.
The platform is being developed to facilitate communication between patients, healthcare providers, and related service participants while supporting structured data collection and workflow coordination across multiple points of care. It is intended to integrate with the company's broader AI healthcare platform, which includes the CardioAI, PulmoAI, and NeuroAI modules. These modules are being developed to provide data-driven analytics and clinical decision-support capabilities, aiming to establish a unified digital infrastructure that supports both healthcare services coordination and analytics-driven insights.
Current development efforts are focused on establishing core platform functionality, including system architecture, data integration, user workflows, and operational processes. The company is also evaluating approaches to support scalability, interoperability, and integration with existing healthcare systems and technologies. Catalyst Crew Technologies is leveraging its wholly-owned subsidiary in Venezuela to support local platform development, operational coordination, and infrastructure planning. Initial efforts are concentrated in Venezuela, with potential expansion into other Latin American markets as development progresses.
Dr. Kevin Rodan Levy, Chief Executive Officer, stated: "We are focused on building a scalable and integrated telehealth platform that can support healthcare coordination and data-driven insights. Our approach is centered on developing infrastructure that can operate within real-world healthcare environments and support future expansion across Latin America."
The company's platform is intended to support healthcare providers and related service participants and does not replace licensed medical professionals or clinical decision-making. For more information, visit https://catalystcrewai.com or review the company's filings with the U.S. Securities and Exchange Commission at www.sec.gov.
This development is significant as it highlights the company's strategic transition into AI-enabled healthcare, addressing the growing demand for modernized healthcare delivery systems in emerging markets. The integration of telehealth with AI analytics modules could improve access, efficiency, and care coordination in regions with limited healthcare infrastructure.
